How should I use Canakinumab(ILARIS)?

Dosage varies by indication, weight, and clinical response.
Weight- and Indication-Based Dosing Regimens

CAPS:

>40 kg: 150 mg SC every 8 weeks.

15–40 kg: 2 mg/kg SC every 8 weeks; may increase to 3 mg/kg if inadequate response.

TRAPS/HIDS/MKD/FMF:

>40 kg: 150 mg SC every 4 weeks; may escalate to 300 mg.

≤40 kg: 2 mg/kg SC every 4 weeks; may escalate to 4 mg/kg.

Still’s Disease (AOSD/SJIA): 4 mg/kg SC (max 300 mg) every 4 weeks for patients ≥7.5 kg.

Gout Flares: 150 mg SC once; re-treatment allowed ≥12 weeks later.
Dose adjustments are guided by clinical efficacy and tolerability.

Canakinumab(ILARIS)
Still’s Disease,Periodic Fever Syndromes
RELATED ARTICLES
How to buy canakinumab?

Canakinumab, also known as canakinumab, Ilaris. Developed by Novartis of Switzerland, it is an effective...

Friday, August 8th, 2025, 15:52
What is the latest price of canakinumab in 2025?

Canakinumab is an effective therapeutic drug for various autoimmune diseases, Still's disease, and gout. Its...

Friday, August 8th, 2025, 15:48
Where can I buy Canakinumab(ILARIS)?

Canakinumab(ILARIS) is a monoclonal antibody drug targeting IL-1β, used to treat a variety of inflammatory...

Tuesday, July 8th, 2025, 13:19
/ 2
4 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved